Mesenchymal Stem Cells Modulate Immune Responses Combined With Cyclosporine in a Rat Renal Transplantation Model

Transplantation Proceedings

Volumn 39, Issue 10, 2007, Pages 3404-3408

  Zhang, W ^a   Qin, C ^a   Zhou, Z M ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; INTERLEUKIN 1; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; GRAFT SURVIVAL; HISTOLOGY; IMMUNOMODULATION; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; LEWIS RAT; LOW DRUG DOSE; MESENCHYMAL STEM CELL; NONHUMAN; PRIORITY JOURNAL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SURVIVAL TIME; WISTAR RAT;

ACTINS; ANIMALS; COMBINED MODALITY THERAPY; CYCLOSPORINE; DISEASE MODELS, ANIMAL; IMMUNOSUPPRESSION; INTERLEUKIN-1; KIDNEY TRANSPLANTATION; MESENCHYMAL STEM CELL TRANSPLANTATION; RATS; RATS, INBRED LEW; RATS, WISTAR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSFORMING GROWTH FACTOR BETA1; TRANSPLANTATION, HOMOLOGOUS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 37049011828     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2007.06.092     Document Type: Article

References (21)

1. De Mattos A.M., Olyaei A.J., and Bennett W.M. Nephrotoxicity of immunosuppressive drugs: long-term consequences and challenges for the future. Am J Kidney Dis 35 (2002) 333
2. Jiang Y., Jahagirdar B.N., Reinhardt R.L., et al. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 418 (2002) 41
3. Deans R.J., and Moseley A.B. Mesenchymal stem cells: biology and potential clinical uses. Exp Hematol 28 (2000) 875
4. Bartholomew A., Sturgeon C., Siatskas M., et al. Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Exp Hematol 30 (2002) 42
5. Djouad F., Plence P., Bony C., et al. Immunosuppressive effect of mesenchymal stem cells favors tumor growth in allogeneic animals. Blood 102 (2003) 3837
6. Tsui T.Y., Jager M.D., Deiwick A., et al. Delayed low-level calcineurin inhibition promotes allospecific tolerance induction by posttransplantation donor leukocyte infusion. Transplantation 73 (2002) 1325
7. Bruder S.P., Jaiswal N., and Haynesworth S.E. Growth kinetics, self-renewal, and the osteogenic potential of purified human mesenchymanl stem cells during extensive subcultivation and following cryopreservation. J Cell Biochem 64 (1997) 278
8. Herzog E.L., Chai L., and Krause D.S. Plasticity of marrow-derived stem cell. Blood 102 (2003) 3483
9. Mark F., Alastair M., Stephen C., et al. Multilineage potential of adult human mesenchymal stem cells. Science 284 (1999) 143
10. Uta K., Song R., Djuric Z., et al. Transplanted mesenchymal stem cells accelerate glomerular healing in experimental glomerulonephritis. J Am Soc Nephrol 17 (2006) 2202
11. Azuma H., Takabara S., Matsumoto K., et al. Hepatocyte growth factor prevents development of chronic allograft nephropathy in rats. J Am Soc Nephrol 12 (2001) 1280
12. Tropel P., Noel D., Platet N., et al. Isolation and characterisation of mesenchymal stem cells from adult mouse bone marrow. Exp Cell Res 295 (2004) 395
13. Sun S., Guo Z., Xiao X., et al. Isolation of mouse marrow mesenchymal progenitors by a novel and reliable method. Stem Cells 21 (2003) 527
14. Martin S., Bruce N., and Paolo F. Kidney transplantation in rats: an appraisal of surgical techniques and outcome. Microsurgery 23 (2003) 387
15. Deng W., Han Q., Liao L., et al. Allogeneic bone marrow-derived flk-1+Sca-1-mesenchymal stem cells leads to stable mixed chimerism and donor-specific tolerance. Exp Hematol 32 (2004) 861
16. Le Blanc K., Rasmusson I., Sundberg B., et al. Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet 363 (2004) 1439
17. Tse W.T., Pendleton J.D., Beyer W.M., et al. Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation. Transplantation 75 (2003) 389
18. Aggarwal S., and Pittenger M.F. Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 105 (2005) 1815
19. Beyth S., Borovsky Z., Mevorach D., et al. Human mesenchymal stem cells alter antigen-presenting cell maturation and induce T-cell unresponsiveness. Blood 105 (2005) 2214
20. Le Blanc K., Rasmusson I., Gotherstrom C., et al. Mesenchymal stem cells inhibit the expression of CD25 (interleukin-2 receptor) and CD38 on phytohaemagglutinin-activated lymphocytes. Scand J Immunol 60 (2004) 307
21. Inoue S., Popp F.C., Koehl G.E., et al. Immunomodulatory effects of mesenchymal stem cells in a rat organ transplant model. Transplantation 81 (2006) 1589